The potential therapeutic regimen for overcoming resistance to osimertinib due to rare mutations in NSCLC

The mechanisms of osimertinib resistance have not been well characterized. We conducted next-generation sequencing to recognize novel resistance mechanism and used cell line-derived xenograft (CDX) and patient-derived xenograft (PDX) models to evaluate the anti-proliferative effects of aspirin in vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Rui, Lin, Caiyu, Zhang, Chong, Kang, Jun, Lu, Conghua, Zhang, Yiming, Wang, Yubo, Hu, Chen, He, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320197/
https://www.ncbi.nlm.nih.gov/pubmed/37416479
http://dx.doi.org/10.1016/j.isci.2023.107105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320197/
https://www.ncbi.nlm.nih.gov/pubmed/37416479
http://dx.doi.org/10.1016/j.isci.2023.107105

Ejemplares similares